655 (Glyburide and Metformin Hydrochloride 5 mg / 500 mg)
Pill with imprint 655 is Yellow, Capsule-shape and has been identified as Glyburide and Metformin Hydrochloride 5 mg / 500 mg. It is supplied by Cadila Healthcare Limited.
Glyburide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glyburide/metformin 5 mg / 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 655
Glyburide and Metformin Hydrochloride
- Imprint
- 655
- Strength
- 5 mg / 500 mg
- Color
- Yellow
- Size
- 16.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 65841-0826
- Inactive Ingredients
-
calcium carbonate,
microcrystalline cellulose,
croscarmellose sodium,
ferric oxide red,
ferric oxide yellow,
ferrosoferric oxide,
hypromellose 2910 (15 mPa.s),
lactose monohydrate,
magnesium stearate,
polyethylene glycol 4000,
povidone k29/32,
titanium dioxide
Note: Inactive ingredients may vary.
Related Images for "655"
More about glyburide / metformin
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 4 Reviews
- Drug class: antidiabetic combinations
- FDA Alerts (1)
Consumer resources
- Other brands
- Glucovance
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.